Release Date: December 24, 2025
Expiration Date: December 24, 2026
Activity Overview
This educational activity is an archive of the live presentation held on November 15, 2025.
For more information about this educational activity, the faculty, and disclosures, please click here.
Target Audience
This educational activity is directed toward medical oncologists, along with advanced practice providers, oncology nurses, and pharmacists who manage patients with lung cancers. Other health care professionals interested in the treatment of lung cancers are also invited to participate.
Learning Objectives
Upon successful completion of this activity, you should be better prepared to:
- Identify key clinical features and red flags of paraneoplastic LEMS
- Apply guideline-recommended processes for diagnosing LEMS and evaluating patients for underlying malignancy
- Initiate evidence-based treatment for LEMS and alignment with SCLC therapy
- Manage treatment-related toxicities associated with LEMS and SCLC therapies
Charu Aggarwal, MD, MPH, FASCO
Leslye M. Heisler Professor for Lung Cancer Excellence
Associate Director, Penn Center for Cancer Care Innovation (PC3I)
Perelman School of Medicine at the University of Pennsylvania
Philadelphia, PA
Erminia Massarelli, MD, PhD, MS
Professor
Division Chief of Hematology/Oncology
Department of Medicine
University of Texas at Tyler School of Medicine
Tyler, TX
Ruham Nasany, MD
Director, Inpatient Neuro-Oncology Service
Assistant Professor of Clinical Neurology
University of Miami Miller School of Medicine
Miami, FL
Full faculty information and disclosures are available by reviewing the program workbook, linked here.
Faculty, Staff, and Planners’ Disclosures
The staff of Physicians’ Education Resource®, LLC (PER®) have no relevant financial relationships with ineligible companies.
PER mitigated all COI for faculty, staff, and planners prior to the start of this activity.
Off-Label Disclosure and Disclaimer
This activity may or may not discuss investigational, unapproved, or off-label use of drugs. Learners are advised to consult prescribing information for any products discussed. The information provided in this accredited activity is for continuing education purposes only and is not meant to substitute for the independent clinical judgment of a health care professional relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER or any company that provided commercial support for this activity.